Market Place
Sourcing Support
Stereotaxis Announces First Magic Procedures In The United States
22 Apr 2026 //
GLOBENEWSWIRE
Stereotaxis To Release Q1 2026 Financial Results On May 12
21 Apr 2026 //
GLOBENEWSWIRE
Stereotaxis Announces Definitive Agreement To Acquire Robocath
15 Apr 2026 //
GLOBENEWSWIRE
Stereotaxis Announces FDA Clearance & Launch of Synchrony System
06 Apr 2026 //
GLOBENEWSWIRE
Stereotaxis Reports 2025 Full Year Financial Results
09 Mar 2026 //
GLOBENEWSWIRE
Stereotaxis To Release 2025 Financial Results On March 9, 2026
12 Feb 2026 //
GLOBENEWSWIRE
Klinikum Fürth Launches Premier Robotic Heart Arrhythmia Program
09 Feb 2026 //
GLOBENEWSWIRE
Stereotaxis Receives FDA Approval For Magic Ablation Catheter
06 Jan 2026 //
GLOBENEWSWIRE
Stereotaxis To Present At Piper Sandler Healthcare Conference
24 Nov 2025 //
GLOBENEWSWIRE
Stereotaxis Reports 2025 Third Quarter Financial Results
11 Nov 2025 //
GLOBENEWSWIRE
Genesisx Robotic Magnetic Navigation System Cleared By FDA
10 Nov 2025 //
GLOBENEWSWIRE
Stereotaxis To Release Q3 2025 Financial Results On Nov 11, 2025
21 Oct 2025 //
GLOBENEWSWIRE
Stereotaxis Launches Synchrony System In EU Submits 510(K)
15 Oct 2025 //
GLOBENEWSWIRE
Stereotaxis, Cardiofocus Partner To Advance Robotic Ablation
13 Oct 2025 //
GLOBENEWSWIRE
Erasmus Med. Center Enhances Cardio Care With Genesis Robotic
22 Sep 2025 //
GLOBENEWSWIRE
Stereotaxis to Present at Upcoming Investor Conferences
02 Sep 2025 //
GLOBENEWSWIRE
First US Robotic HD Mapping Done With MAGiC Sweep Catheter
02 Sep 2025 //
GLOBENEWSWIRE
Stereotaxis Tech Showcased at Heart Rhythm Society`s HRX 2025
28 Aug 2025 //
GLOBENEWSWIRE
Stereotaxis Reports 2025 Second Quarter Financial Results
07 Aug 2025 //
GLOBENEWSWIRE
Stereotaxis Gets FDA Clearance for MAGiC Sweep Catheter
28 Jul 2025 //
GLOBENEWSWIRE
Stereotaxis to Report Q2 2025 Financial Results on August 7
23 Jul 2025 //
GLOBENEWSWIRE
Stereotaxis Announces $12.5M Offering of Common Stock
17 Jul 2025 //
GLOBENEWSWIRE
MAGiC Catheter Study Results Published in Cardio Journal
01 Jul 2025 //
GLOBENEWSWIRE
Stereotaxis Reports 2025 First Quarter Financial Results
12 May 2025 //
GLOBENEWSWIRE
Stereotaxis to Report Q1 2025 Financial Results on May 12, 2025
22 Apr 2025 //
GLOBENEWSWIRE
Stereotaxis to Demo GenesisX Robotic System at HRS 2025
21 Apr 2025 //
GLOBENEWSWIRE
Stereotaxis Highlighted By NVIDIA & Joins Connect Program
19 Mar 2025 //
GLOBENEWSWIRE
Stereotaxis to Present at 37th Annual Roth Conference
10 Mar 2025 //
GLOBENEWSWIRE
Stereotaxis Reports 2024 Full Year Financial Results
03 Mar 2025 //
GLOBENEWSWIRE
Stereotaxis Seeks Nod For First Robotically Navigated EP Catheter
03 Mar 2025 //
GLOBENEWSWIRE
Stereotaxis Seeks Clearance For EMAGIN Robotic Catheter
03 Mar 2025 //
GLOBENEWSWIRE
Stereotaxis to Present at TD Cowen Healthcare Conference
25 Feb 2025 //
GLOBENEWSWIRE
Stereotaxis to Report Q4 & Full Year Financial Results on March 3
03 Feb 2025 //
GLOBENEWSWIRE
Stereotaxis Announces First GenesisX Robotic System Order
30 Jan 2025 //
GLOBENEWSWIRE
Stereotaxis Receives CE Mark Approval for MAGiC Ablation Catheter
27 Jan 2025 //
GLOBENEWSWIRE
Oulu Hospital Enhances Arrhythmia Care With Genesis Robotic Tech
14 Jan 2025 //
GLOBENEWSWIRE
Magbot Robotic Magnetic Navigation Catheter Approved by China NMPA
09 Dec 2024 //
GLOBENEWSWIRE
Stereotaxis’ GenesisX To Debut At RSNA 2024 With Neusoft Medical
02 Dec 2024 //
GLOBENEWSWIRE
Stereotaxis to Attend Piper Sandler 36th Annual Health Conference
26 Nov 2024 //
GLOBENEWSWIRE
Stereotaxis Genesis Robotic System Gets Regulatory Approval in China
25 Nov 2024 //
GLOBENEWSWIRE
Hospital Da Luz First In Portugal To Adopt Genesis Robotic System
20 Nov 2024 //
GLOBENEWSWIRE
Stereotaxis Reports 2024 Q3 Financial Results
11 Nov 2024 //
GLOBENEWSWIRE
University of Kansas Enhances Robotic Heart Care with Genesis Tech
06 Nov 2024 //
GLOBENEWSWIRE
Stereotaxis Q3 2024 Financial Results on November 11
23 Oct 2024 //
GLOBENEWSWIRE
Stereotaxis Featured At Annual Meeting Of Cardiac Robotic Navigation
21 Oct 2024 //
GLOBENEWSWIRE
Stereotaxis to Present at Upcoming Investor Conferences
09 Sep 2024 //
GLOBENEWSWIRE
Stereotaxis Robotic Tech Featured at Heart Rhythm Society`s HRX Congress
03 Sep 2024 //
GLOBENEWSWIRE
Stereotaxis Gets CE Mark For GenesisX, Submits 510(k) In US
12 Aug 2024 //
GLOBENEWSWIRE
Stereotaxis Reports 2024 Second Quarter Financial Results
12 Aug 2024 //
GLOBENEWSWIRE
Stereotaxis to Report Second Quarter 2024 Financial Results on August 12, 2024
22 Jul 2024 //
GLOBENEWSWIRE
Stereotaxis Strengthens Board of Directors with Appointment of Nachum Shamir
18 Jul 2024 //
GLOBENEWSWIRE
Penn Presbyterian First In Northeast With Robotic Heart Treatment
29 May 2024 //
GLOBENEWSWIRE
Stereotaxis Receives CE Mark Recertification Under EU`s MDR Regulatory Framework
24 May 2024 //
GLOBENEWSWIRE
First Robotic Heart Rhythm Treatment In Southern Italy
22 May 2024 //
GLOBENEWSWIRE
Stereotaxis Invited To Present Robotic Solution For Therapy Access In Africa
15 May 2024 //
GLOBENEWSWIRE
Stereotaxis Announces Definitive Agreement to Acquire Access Point Technologies
13 May 2024 //
GLOBENEWSWIRE
Stereotaxis Reports 2024 First Quarter Financial Results
13 May 2024 //
GLOBENEWSWIRE
Stereotaxis to Report First Quarter 2024 Financial Results on May 13, 2024
22 Apr 2024 //
GLOBENEWSWIRE
Stereotaxis Reports 2023 Full Year Financial Results
04 Mar 2024 //
GLOBENEWSWIRE
Stereotaxis Announces Regulatory Submissions of the MAGiC Ablation Catheter
04 Mar 2024 //
GLOBENEWSWIRE
